David Vincent

David Vincent has worked in the pharmaceutical industry since 2009. David began their career at MedImmune as an Associate Scientist I and R&D Associate II from 2009 to 2012. David then moved on to University College London as a Research Engineer from 2012 to 2016, where they worked on purification and analytical development of recombinant vaccinia virus, as well as developing CoG/risk analysis to identify major risks and cost drivers for process development and evaluating microfluidic technology for use in downstream processing. In 2016, they joined Pfizer as a Downstream Process Development Scientist. Finally, from 2017 to present, they have been employed at eXmoor Pharma Concepts Ltd, where they have held the roles of Head of Process Development, Head of Vector, Process Development Lead (DSP), and Bioprocess Engineer.

David Vincent completed their BSc (Hons) in Biological Sciences at the University of Exeter between 2006 and 2008. David then went on to pursue a MSc in Biochemical Engineering at UCL from 2008 to 2009. Following this, they completed a MRes in Biochemical Engineering at UCL from 2012 to 2013. Finally, they completed an EngD in Biochemical Engineering at UCL from 2013 to 2016.